NEUROGENIX XL Trademark

Trademark Overview


On Thursday, September 16, 2021, a trademark application was filed for NEUROGENIX XL with the United States Patent and Trademark Office. The USPTO has given the NEUROGENIX XL trademark a serial number of 97031618. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 26, 2023. This trademark is owned by Centinela Medical Center of South Bay Inc.. The NEUROGENIX XL trademark is filed in the Pharmaceutical Products category with the following description:

Natural herbal supplements; Nutraceuticals for use as a dietary supplement for cognitive function, focus and concentration, memory, mental clarity, and brain function; Vitamin and mineral supplements
neurogenix xl

General Information


Serial Number97031618
Word MarkNEUROGENIX XL
Filing DateThursday, September 16, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Goods and ServicesNatural herbal supplements; Nutraceuticals for use as a dietary supplement for cognitive function, focus and concentration, memory, mental clarity, and brain function; Vitamin and mineral supplements
Translation of Words in MarkThe wording NEUROGENIX XL has no meaning in a foreign language.
Disclaimer with Predetermined Text"XL"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code005
First Use Anywhere DateThursday, June 11, 2020
First Use In Commerce DateThursday, June 11, 2020

Trademark Owner History


Party NameCentinela Medical Center of South Bay Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawndale, CA 90260

Trademark Events


Event DateEvent Description
Thursday, October 26, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 26, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 26, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 12, 2023NON-FINAL ACTION E-MAILED
Wednesday, July 12, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 31, 2023SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, November 18, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 18, 2022LETTER OF SUSPENSION E-MAILED
Friday, November 18, 2022SUSPENSION LETTER WRITTEN
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2022NON-FINAL ACTION WRITTEN
Friday, May 6, 2022ASSIGNED TO EXAMINER
Thursday, October 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 20, 2021NEW APPLICATION ENTERED